SB5029 - A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
US Congress - 118th Congress
Introduced byBill Cassidy
Last updated 11 days ago
1 Co-Sponsor
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now